Search results
FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall (NYSE:PFE)
Seeking Alpha· 3 days agoA panel of advisors unanimously agrees on the need for a monovalent COVID-19 shot targeting the JN.1...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
Reuters· 3 days agoCOVID-19 vaccine makers said data from animals studies showed their 2024-25 shots targeting the JN.1...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
WKBT La Crosse· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
FDA vaccine advisers vote unanimously in favor of updated COVID-19 shot for fall
WPTZ Burlington· 2 days agoThe Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KTBS Shreveport· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to recommend that the agency tell vaccine manufacturers to update the Covid-19 shots so they ...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 2 days agoThe vaccine is based on protein technology, which is appealing to people hesitant to use the newer...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via AOL· 3 days ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 3 days agoCOVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 3 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 2 days agoIn a filing with the Securities and Exchange Commission, Novavax said the FDA said it completed its...